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Endoluminal negative pressure wound treatment of
anastomotic leakage in rectal surgery patients –
critical review of the literature
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REVIEW
Abstract—During past 20 years, the use of negative pressure
wound therapy (NPWT) has shown its effectiveness and efficiency
in the treatment of various indications. These indications include
treatment of septic complications of open surgery (open abdomen,
entero-atmospheric fistulas, wound dehiscence including post-
sternotomy infections, staged abdominal wall repair, diabetic foot
syndrome, and salvage of infected prosthetic material) or their
prevention (prevention of complications in skin graft application
and prevention of prosthetic graft infection).
New approaches and ways of application are evolving. One of
the new therapeutic methods is endoluminal use in both upper
and lower gastrointestinal tract. Authors performed and present
a thorough review of the literature on the use of endoluminal
NPWT in anastomotic leakage in rectal surgery patients.
Authors conclude that ”endo-NPWT” (NPWT used in the lu-
men of the gastrointestinal tract) is becoming a new and effective
therapeutic method in the treatment of septic complications of
patients after rectal surgery.
Keywords—anastomotic leakage, NPWT, VAC, wound healing,
endo-NPWT
I. INTRODUCTION
S INCE its introduction, negative pressure wound therapy(NPWT) has shown its effectiveness and efficiency in
a number of different indications. These indications include
treatment of septic complications of open surgery (including
open abdomen and management of entero-atmospheric fistu-
las,1 wound dehiscence including sternotomy infections,2 dif-
ferent possibilities of staged abdominal wall repair,3, 4 diabetic
foot syndrome,5 and salvage of infected prosthetic material6
or their prevention (prevention of complications in skin graft
application7 and prevention of prosthetic graft infection8).
Such uses consist of either external application — directly
in the wound or intracorporal applications (intra-abdominal
NPWT, intra-thoracic NPWT).
New approaches and ways of application of NPWT are
evolving. One of the newest therapeutic methods is the en-
doluminal use of NPWT in the lumen of both upper and
lower gastrointestinal tract. This method was first described
in 20069 even though the first patients were treated as early
as in 2001.10 Indication for such use is dehiscence and leakage
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of an anastomosis in the gastrointestinal tract without signs of
peritonitis. The rationale of such therapy is infection source
control and filling of the abscess cavity with granulation
tissue with subsequent over-epithelization. The benefit of such
procedure are: no need for reoperation with disconnection and
salvage stoma creation (Torek operation in esophageal surgery,
Hartmann operation in rectal surgery). The initial literature on
the endoluminal use of NPWT suggests positive results but its
value and its role in the treatment of patients with anastomotic
leakages has to be evaluated.
We performed a thorough review of the literature on the use
of endoluminal NPWT in patients with anastomotic leakage in
rectal surgery in attempt to describe its current indications and
possible uses.
II. METHODS
Authors performed a literature search through Web of
Knowledge (Thomson Reuters) including Web of Science R©
(Science Citation Index Expanded (SCI-E), Social Science
Citation index (SSCI), Conference Proceedings Citation Index
– Science (CPCI-S), Conference Proceedings Citation Index
– Social Sciences & Humanities (CPCI-SSH), Book Citation
Index – Science (BKCI-S), Book Citation Index – Social Sci-
ences & Humanities (BKCI-SSH), BIOSIS Citation IndexSM,
Current Contents Connect R©, MEDLINE R©, Journal Citation
Reports R©, and Scopus R©. Search terms were combination of
phrases: ”VAC”, ”NPWT”, ”negative pressure wound ther-
apy”, ”vacuum assisted closure”, ”endoluminal VAC”, and
”endoluminal NPWT”.
All results were processed with the search for articles, where
endoluminal negative pressure was used for the treatment
of anastomotic leakage after rectal surgery and included a
group of patients. These articles were further analyzed in
terms of indication, type or construction of NPWT, level of
negative pressure used, number of redresses done, length of
treatment, stoma creation, and outcome of treatment in terms
of morbidity and mortality.
III. RESULTS
After performing literature search we identified 12 articles,
where endoluminal negative pressure was used for treatment
of anastomotic leakage after rectal surgery.9–20 These papers
are summarized in table I.
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The number of treated patients in all but two papers are low
(1–5 patients) in exception for two papers by Weidenhagen
et al. both published in 2008, where 60 ad 34 patients were
described respectively.10, 13 It is not clear from the papers,
if the patients described are not repetitively presented (one
group is described as treated from 2001 till 2008, second is
from 2002 to 2004). Anyhow, no more than 159 patients are
presented in the literature as being treated with such method.
Anastomotic leakage after low anterior resection was re-
ported as the main indication for treatment with endo-NPWT.
In minority authors also recommended it in anastomotic leak-
age of ileoanal ”J-pouch” anastomosis or perforation after
stapled hemorrhoidectomy.
Currently, the only industrially made available unit is En-
doSPONGE (Braun Medical, Braun Melsungen AG, Ger-
many). This unit does not however allow to regulate negative
pressure as well as lacks automatic signalization of vacuum
loss and vacuum recreation. Because of this, different im-
provised techniques have been developed. They consist of a
pyramid or oval shaped polyurethane foam (black foam) in
conjunction with most commonly used NPWT units – either
with VAC9 (KCI, San Antonio, TX, USA) or Vivano18 (Paul
Hartmann AG, Heidenheim, Germany). Black foam is sutured
to the tubing and then used with continuous negative pressure
as in intra-abdominal NPWT.
Treatment technique starts with irrigation of an abscess
cavity with a possibility of endoscopic debridement.14 With
the help of anoscope or endoscope, the foam is placed inside
the cavity. Some authors proclaim, that foam should not
be in contact with the mucosa, others describe intracolonic
placement of NPWT.18 Redresses are done every 2–4 days
until abscess cavity is shallow or fistula has regressed. This
may take as long as 8 weeks. Some authors describe, that
redresses in the later period may be done in ambulatory
setting.13
The success rate of leakage control is as high as 75–
100% as opposed to 60% in patients with transrectal lavage
and debridement,9 or 50% in conservatively treated animal
model.21
The mortality rate in all patient groups is very low (2
patients) and independent from the medical condition treated
(one intracerebral hemorrhage and one craniocerebral trauma
after a fall from the bed).
Concerning stoma creation, most of the patients had it done
either during the primary operation or during endo-NPWT,
where it might complicate treatment with fecal impaction.
Stoma reversal after healing is possible in most patients
(88%14).
IV. DISCUSSION
Anastomotic leakage is the most important complication
of anterior rectal resection and rectal resection surgery and
is the main cause for the high level of patient mortality
and morbidity.22 It can lead to generalized peritonitis, with
a severe septic progression involving multiple organ failure
and potentially resulting in the death of the patient.
Clinically manifesting anastomotic leakages occur in ap-
prox. 15% of patients following rectal resection.23 The fre-
quency depends on various patient characteristics, the height
of the anastomosis, technique of anastomosis creation, and the
prior treatment in the case of carcinomas.
The possibilities and therapeutic principles concerning anas-
tomotic leakage remain the subject of controversial discus-
sion to this day. The spectrum of possible treatments ranges
from conservative measures such as broad antibiotic coverage,
through drainage and an endoscopic irrigation up to surgical
revision with stoma placement, a Hartmann operation or,
finally, abdominoperineal extirpation. A potential drawback
of surgical relaparotomy and stoma creation is the general
morbidity of diverting stomas of up to 30% and the reduced
reversal rate of under 50% in anastomotic leakage.24 The
particular procedure varies according to the point in time, the
extent and localization of the anastomotic leakage, as well
as the efficiency of the secretion drainage and the clinical
condition of the patient. No controlled studies yet exist on the
various different methods for treating anastomotic leakages.25
Recently, the introduction of NPWT and its endoluminal
use in the treatment of such defects showed promising results
not only in experimental setting,21 but also in clinical one.
The rationale of treatment is the reduction of a septic burden
by local debridement and negative pressure, evacuation of
inflammatory cytokines and metabolites, promotion of gran-
ulation tissue and enhanced tissue perfusion. All these aspects
cause the defect to decrease in size and after being shallow or
small, it can be left for spontaneous closure.
Nagell et al.9 used this technique in four patients with
anastomotic leakage after rectal surgery, using PUR foam
in conjunction with KCI unit (KCI, San Antonio, Texas,
USA). As compared to control group of ten patients treated
conservatively, the successful management was higher by 15%.
Markedly higher was rate of healing, where patients in control
group healed approximately in twice the time, as patients in
treated group. Interesting information is that the healing rate of
patients after neoadjuvant radiotherapy is markedly higher than
those, who did not undergo this treatment (195 days vs. 43–
51 days). Mees et al.11 also compared two groups of patients,
where the control group was treated with transrectal lavage.
The rate of healing was significantly higher in patients treated
with endo-NPWT.
Van Koperen et al.12 used the method in the treatment of
anastomotic leakage of ileoanal J-pouch anastomosis, using
EndoSPONGE. Both presented patients were successfully
managed with this technique and recovered in 8 weeks.
Weidenhagen et al.10, 13 published two papers with a large
group of patients with anastomotic leakage after rectal surgery.
They presented successful management of over 80% of pa-
tients with a mean time of treatment being just over one
month. The work, that is presented in both papers, in col-
laboration with ”BBraun Melsungen AG, Germany” led to
the development of EndoSPONGE technique and inventory.
Arezzo et al.16 and Veloso et al.17 both show the efficacy of
EndoSPONGE treatment of patients with anastomosis leakage
after lower anterior colon resection. In both papers, all patients
were successfully managed with this technique.
Chopra et al.14 compared the endoscopically treated group
as opposed to surgically treated patients. The resolution rate
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of leakage was 77%. Durai et al.15 showed an interesting case,
where perforation occured as a complication of stapled hemor-
rhoidectomy. Authors used a combination of VAC and Redivac
for successful management of this complication. Hutan et al.18
showed interesting case of anastomosis dehiscence of ileoanal
J-pouch. Patient was treated with improvised Vivano system
(Paul Hartmann AG, Heidenheim, Germany).
Although challenging, time and energy consuming (because
of high frequency of redresses in the operation theater setting),
this method gives the surgeon another powerful tool in local
management of septic complication of reconstruction surgery
in the rectal and anal area.
V. CONCLUSION
Endo-NPWT is becoming a new and powerful tool for the
local management of septic complications, following rectal
surgery. The data show a higher rate of treatment with a
higher success rate. For further and wider application and
development of this method, more patients have to be treated
and analyzed, but based on literature studies, the preliminary
results are very promising and this method should be consid-
ered as an option in patients with indications.
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